Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 15.

Vassalli, Giuseppe; Klersy, Catherine; De Servi, S; Erne, Paul; Eberli, F; Rickli, Hans; Hornig, B; Bertel, O; Bonetti, P; Moccetti, T; Kaiser, C; Pfisterer, Matthias E; Pedrazzini, Giovanni (2016). Can the optimal type of stent be predicted based on clinical risk factors ? A subgroup analysis of the randomized BASKET-PROVE trial. American Heart Journal, 173:1-7.

Klauss, V; Serruys, P W; Pilgrim, T; Buszman, P; Linke, A; Ischinger, T; Eberli, F; Corti, R; Wijns, W; Morice, M; di Mario, C; van Geuns, R; van Es, G; Kalesan, B; Wenaweser, P; Jüni, P; Windecker, S (2011). 2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice. JACC: Cardiovascular Interventions, 4(8):887-895.

Wykrzykowska, J J; Garg, S; Onuma, Y; de Vries, T; Morel, M; van Es, G; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Corti, R; Eberli, F; Wijns, W; Morice, M; Di Mario, C; van Geuns, R; Juni, P; Windecker, S; Serruys, P W (2011). Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial. EuroIntervention, 7(5):605-13.

Stefanini, G G; Kalesan, B; Serruys, P W; Heg, D; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Eberli, F; Wijns, W; Morice, M; Di Mario, C; Corti, R; Antoni, D; Sohn, H Y; Eerdmans, P; van Es, G; Meier, B; Windecker, S; Jüni, P (2011). Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet, 378(9807):1940-1948.

Pedrazzini, G B; Radovanovic, D; Vassalli, G; Sürder, D; Moccetti, T; Eberli, F; Urban, P; Windecker, S; Rickli, H; Erne, P (2011). Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience. JACC: Cardiovascular Interventions, 4(6):627-633.

Garg, S; Wykrzykowska, J; Serruys, P W; de Vries, T; Buszman, P; Trznadel, S; Linke, A; Lenk, K; Ischinger, T; Klauss, V; Eberli, F; Corti, R; Wijns, W; Morice, M; di Mario, C; Tyczynski, P; van Geuns, R J; Eerdmans, P; van Es, G; Meier, B; Jüni, P; Windecker, S (2011). The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer. EuroIntervention, 6(8):928-935.

Fassa, A A; Urban, P; Radovanovic, D; Eberli, F; Polikar, R; Stauffer, J C; Bertel, O; Erne, P (2010). Impact of comorbidities on clinical presentation, management and outcome of patients with acute coronary syndrome. Cardiovascular Medicine, 13(5):155-161.

Garg, S; Sarno, G; Serruys, P W; de Vries, T; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Eberli, F; Corti, R; Wijns, W; Morice, M C; Di Mario, C; van Geuns, R J; Eerdmans, P; van Es, G A; Meier, B; Jüni, P; Windecker, S (2010). The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. EuroIntervention, 6(2):233-239.

Wykrzykowska, J J; Garg, S; Girasis, C; de Vries, T; Morel, M A; van Es, G A; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Corti, R; Eberli, F; Wijns, W; Morice, M C; di Mario, C; van Geuns, R J; Juni, P; Windecker, S; Serruys, P W (2010). Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. Journal of the American College of Cardiology, 56(4):272-277.

Wykrzykowska, J J; Räber, L; de Vries, T; Bressers, M; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Eberli, F; Corti, R; Wijns, W; Morice, M C; di Mario, C; Regar, E; Juni, P; Windecker, S; Serruys, P W (2009). Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy. EuroIntervention, 5(3):310-317.

Serruys, P W; Wykrzykowska, J J; Onuma, Y; de Vrie, T; Avan Es, G; Buszman, P; Linke, A; Ischinger, T; Klauss, V; Corti, R; Eberli, F; Wijns, W; Moprice, M C; di Mario, C; van Geuns, R J; Juni, P; Windecker, S (2009). Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. JACC: Cardiovascular Interventions, 2(9):861-870.

Plass, A; Schepis, T; Scheffel, H; Eberli, F; Kaufmann, P; Alkadhi, H; Prêtre, René; Grünenfelder, J (2008). Multimodality preoperative planning and postoperative follow-up of a hybrid cardiac intervention. Heart Surgery Forum, 11(6):E375-E377.

Plass, A; Grunenfelder, J; Leschka, S; Alkadhi, H; Eberli, F; Wildermuth, S; Zund, G; Genoni, M (2006). Coronary artery imaging with 64-slice computed tomography from cardiac surgical perspective. European Journal of Cardio-Thoracic Surgery, 30(1):109-116.

Szucs, T D; Schwenkglenks, M; Lüscher, T F; Eberli, F (2005). Die Wirtschaftlichkeit beschichteter Stents in der interventionellen Kardiologie - eine gesamtschweizerische Analyse. Kardiovaskuläre Medizin, 8:41-52.

Eberli, F (2004). Stunned myocardium?an unfinished puzzle. Cardiovascular Research, 63(2):189-191.

This list was generated on Sat Dec 15 03:19:07 2018 CET.